Caterina Nardella - Concepedia

Author

Caterina Nardella

Beth Israel Deaconess Medical Center ORCID

Also Known As

C Nardella, C. Nardella, Caterina Nardella

110

Publications

5.6K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Cancer Genetics (United States)Memorial Sloan Kettering Cancer Center Harvard University Dana-Farber Cancer Institute

About

Caterina Nardella is an author at Beth Israel Deaconess Medical Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	2.1K
2	Cell Biology	6	6	1.3K
3	Health Sciences	1	1	14
4	Natural Sciences	1	1	117
5	Microbiology	1	1	20

Caterina Nardella

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer Arkaitz Carracedo, Li Ma, Julie Teruya‐Feldstein, Journal of Clinical Investigation	2008	1.4K
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate Brett S. Carver, Jennifer Tran, Anuradha Gopalan, Nature Genetics UrologySignal TransductionSignaling PathwayCancer ProgressionTumor Suppressor	2009	658
Subtle variations in Pten dose determine cancer susceptibility Andrea Alimonti, Arkaitz Carracedo, John G. Clohessy, Nature Genetics MedicineMetronomic TherapySubtle VariationsOncologyRadiation Oncology	2010	567
Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer Ashish Juvekar, Laura N. Burga, Hai Hu, Cancer Discovery	2012	475
Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence Hui-Kuan Lin, Zhenbang Chen, Guocan Wang, Nature Tumor BiologyMedicineCellular SenescenceTumor SuppressorCancer Biology	2010	394
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis Andrea Alimonti, Caterina Nardella, Zhenbang Chen, Journal of Clinical Investigation	2010	352
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer Andrea Lunardi, Ugo Ala, Mirjam T. Epping, Nature Genetics Potential TherapiesUrologyGenitourinary CancerMedicineAndrogen Deprivation Resistance	2013	143
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion Guocan Wang, Andrea Lunardi, Jiangwen Zhang, Nature Genetics Tumor InvasionTranscriptional RegulationMedicineCancer Cell BiologyCellular Senescence Bypass	2013	139
Aberrant <i>Rheb</i>-mediated mTORC1 activation and <i>Pten</i> haploinsufficiency are cooperative oncogenic events Caterina Nardella, Zhenbang Chen, Leonardo Salmena, Genes & Development Molecular BiologyCancer BiologyTumor BiologyCooperative Oncogenic EventsSignaling Pathway	2008	117
Vulnerabilities of <i>PTEN</i> – <i>TP53</i> -Deficient Prostate Cancers to Compound PARP–PI3K Inhibition Enrique González‐Billalabeitia, Nina Seitzer, Su Jung Song, Cancer Discovery	2014	89

Page 1